Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Benicar Lawsuits Over Sprue-Like Enteropathy Begin to Mount in Federal Courts December 10, 2014 Irvin Jackson Add Your Comments Daiichi Sankyo and Forest Laboratories face a growing number of product liability lawsuits filed in U.S. District Courts throughout the country involving allegations that inadequate warnings were provided about the risk of chronic diarrhea and sprue-like enteropathy from side effects of Benicar. While a number of Benicar lawsuits have been filed over the past six months in New Jersey state court, there has been a recent up-tick in complaints filed in the federal court system. At least three lawsuits have been filed over the last week, with two cases filed in the U.S. District Court for the Northern District of Ohio and a third filed in the U.S. District Court for the District of Oregon. Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION On December 5, a complaint (PDF) filed by Annette M. Johnson indicates that Benicar caused her to be hospitalized on multiple occasions due to chronic diarrhea, acute kidney failure, severe anemia, weakness, nausea and weight loss. The same day, a nearly identical complaint (PDF) was filed by Pamela Bonner, describing similar injuries following use of the blood pressure drug, which also resulted in repeated hospitalizations. This week, on December 8, a complaint (PDF) filed by James Manley in Oregon indicates that Benicar caused him to develop sprue-like enteropathy, resulting in multiple hospitalizations and leaving him with several other ailments that were caused by the chronic diarrhea and the various treatments doctors recommended to alleviate the problems that were caused by Benicar. As Benicar injury lawyers continue to review and evaluate cases for individuals nationwide, as more and more lawsuits are brought in the federal court system, it is likely that a motion may soon be filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) seeking to centralize the cases before one judge for coordinated pretrial proceedings and possibly a series of early “bellwether” trials, which would be designed to facilitate possible Benicar settlements among the various cases involving similar allegations. Benicar Sprue-Like Enteropathy Risks Benicar (olmesartan medoxomil) is part of a family of Daiichi Sankyo hypertension drugs, which also includes Benicar HCT, Azor and Tribenzor. All of the blood pressure drugs include the active ingredient olmesartan, which has been linked to the development sprue-like enteropathy. Although the medication has been on the market for more than 10 years, information about the link between Benicar and diarrhea problems were not recognized within the medical community until recently, resulting in many former users experiencing complications from the medication for years. In many cases, users have repeatedly been hospitalizations because doctors were unaware that the symptoms may be caused by their blood pressure medication. The Benicar problems have often been misdiagnosed as Celiac disease or unclassified sprue, resulting in continued use of the medication, which could leave users with long-term intestinal damage. Although the diarrhea symptoms associated with sprue-like enteropathy typically resolve when the medication is no longer used, the problems can cause permanent damage to the intestines, known as villous atrophy from Benicar. The first information about the risk was not provided until June 2013, when the FDA required Daiichi Sankyo to update the Benicar warning label more than 10 years after the drug was first introduced. The updated warnings informed doctors that users may develop symptoms of sprue-like enteropathy months or even years after first use of the drug. The federal drug regulators indicated that there was clear evidence of a causal connection, as most Benicar users suffering chronic diarrhea, weight loss or other gastrointestinal complications had the symptoms resolve when the medication was no longer used, with the issues returning if the medication is resumed. Earlier this year, a number of users who experienced complications began filing lawsuits over Benicar in New Jersey state court, which is where Daiichi Sankyo’s U.S. headquarters are based. While the drug makers did attempt to remove several early Benicar lawsuits to the federal court systems, plaintiffs were successful in obtaining remand back to New Jersey state court. The complaints filed in both New Jersey state court and in various federal district courts raise similar allegations, claiming that the drug makers knew or should have known about the risk of problems with Benicar for years, yet withheld information about the fact that symptoms of sprue-like enteropathy that appear at any time following use may be caused by the drug. Tags: Benicar, Daiichi Sankyo, Enteropathy, Forest Laboratories, Hypertension, Sprue, Villous Atrophy More Benicar Lawsuit Stories Benicar Recall Urged in FDA Petition Filed by Public Citizen December 8, 2017 Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017 Benicar Lawsuits Over Diarrhea, Gastrointestinal Problems Filed By Nearly 2,000 July 17, 2017 1 Comments cynthia December 11, 2014 I was told that Benicar could be fatal when I walked into a hospital emergency room on 10-25-2008 a had swelling around my eyes and face and since then I had to have a heart stent 6months later I ended having gastrointestinal problems stomach problem I was told about 2weeks ago my medication might not be taking to good because of my stomach I have had problem after problem and I pretty sure it is because on the Benicar I could go on and on Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: today) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: today) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)